This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Medina, D. Articles by Schwartz, M. Search for Related Content PubMed PubMed Citation Articles by Medina, D. Articles by Schwartz, M.

Morphological and Functional Properties of TM Preneoplastic Mammary Outgrowths¹

Baylor College of Medicine, Department of Cell Biology, Houston, Texas 77030

The TM series of preneoplastic mammary outgrowth lines was derived from the transplantation of the FSK mammary cell lines into the cleared mammary fat pads of syngeneic female BALB/c mice. The tumor-producing capabilities of the 6 TM outgrowth lines varied from high (TM2, -4, -6) to low (TM9, -10) to nil (TM3). Outgrowth lines 2, 4, and 6 each segregated into sublines of high and low tumor potential. The majority of the outgrowth lines exhibited a moderate to dense alveolar hyperplasia typical of mouse mammary hyperplasias. The exceptions to this picture were lines TM2H and TM10 which exhibited a unique ductular morphology. The ductular morphology was not correlated with tumor potential of the outgrowth lines but was correlated with the expression of K6 and K14 keratins in luminal epithelial cells. In an examination of the growth and hormonal responsiveness properties of the TM outgrowth lines, the TM3 line stands as distinct from the other lines and from any other lines previously characterized in BALB/c mice. The TM3 line grew very slowly and failed to fill the fat pad by 12 months of age. At 12 months of age, the alveolar hyperplasia had regressed so that only bare ducts were present. The TM3 outgrowth was ovarian hormone dependent for growth and alveolar differentiation. TM3 outgrowth represents a minimally deviated mammary hyperplasia which has acquired the immortal phenotype but not the other phenotypic characteristics of mammary preneoplasias. This outgrowth line will be useful for examining the essential molecular changes important for the preneoplastic state, some of which are reported in an accompanying paper (D. Medina et al., Cancer Res., 53: 668–674, 1993).

¹ Supported by National Cancer Institute Research Grant CA-47112.

Received 7/20/92. Accepted 11/19/92.

This article has been cited by other articles:

				D. Medina and F. Kittrell Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia J. Cell Sci., January 1, 2005; 118(1): 123 - 127. [Abstract] [Full Text] [PDF]

				G. Chakravarty, D. Hadsell, W. Buitrago, J. Settleman, and J. M. Rosen p190-B RhoGAP Regulates Mammary Ductal Morphogenesis Mol. Endocrinol., June 1, 2003; 17(6): 1054 - 1065. [Abstract] [Full Text] [PDF]

				W. Jiang, Z. Zhu, N. Bhatia, R. Agarwal, and H. J. Thompson Mechanisms of Energy Restriction: Effects of Corticosterone on Cell Growth, Cell Cycle Machinery, and Apoptosis Cancer Res., September 15, 2002; 62(18): 5280 - 5287. [Abstract] [Full Text] [PDF]

				Z. Zhu, W. Jiang, H. E. Ganther, and H. J. Thompson Mechanisms of Cell Cycle Arrest by Methylseleninic Acid Cancer Res., January 1, 2002; 62(1): 156 - 164. [Abstract] [Full Text] [PDF]

				W. Shi and M. N. Gould Induction of cytostasis in mammary carcinoma cells treated with the anticancer agent perillyl alcohol Carcinogenesis, January 1, 2002; 23(1): 131 - 142. [Abstract] [Full Text] [PDF]

				S. G. Bonnette and D. L. Hadsell Targeted Disruption of the IGF-I Receptor Gene Decreases Cellular Proliferation in Mammary Terminal End Buds Endocrinology, November 1, 2001; 142(11): 4937 - 4945. [Abstract] [Full Text] [PDF]

				Y. Liu, H. Asch, and M. F. Kulesz-Martin Functional Quantification of DNA-binding Proteins p53 and Estrogen Receptor in Cells and Tumor Tissues by DNA Affinity Immunoblotting Cancer Res., July 1, 2001; 61(14): 5402 - 5406. [Abstract] [Full Text] [PDF]

				G. Chakravarty, D. Roy, M. Gonzales, J. Gay, A. Contreras, and J. M. Rosen p190-B, a Rho-GTPase-activating Protein, Is Differentially Expressed in Terminal End Buds and Breast Cancer Cell Growth Differ., July 1, 2000; 11(7): 343 - 354. [Abstract] [Full Text]

				C. Ip, H. J. Thompson, Z. Zhu, and H. E. Ganther In Vitro and in Vivo Studies of Methylseleninic Acid: Evidence That a Monomethylated Selenium Metabolite Is Critical for Cancer Chemoprevention Cancer Res., June 1, 2000; 60(11): 2882 - 2886. [Abstract] [Full Text] [PDF]

				P Schedin, R Strange, T Mitrenga, P Wolfe, and M Kaeck Fibronectin fragments induce MMP activity in mouse mammary epithelial cells: evidence for a role in mammary tissue remodeling J. Cell Sci., January 3, 2000; 113(5): 795 - 806. [Abstract] [PDF]

				S. G. Bonnette, F. S. Kittrell, L.C. Stephens, R. E. Meyn, and D. Medina Interactions of apoptosis, proliferation and host age in the regression of the mouse mammary preneoplasia, TM3, carrying an unusual mutation in p53 Carcinogenesis, September 1, 1999; 20(9): 1715 - 1720. [Abstract] [Full Text] [PDF]